Latest Shareholder Approval News

Arafura Rare Earths Limited has announced a Share Purchase Plan (SPP) targeting $50 million to support its Nolans Project, subject to shareholder approval. The offer allows eligible shareholders to subscribe for shares at a discounted price, with potential oversubscriptions up to $20 million.

Seven West Media reports a 6% EBITDA rise in H2 FY25 driven by TV and digital growth, while announcing a transformative merger with Southern Cross Media.

Javelin Minerals has initiated a significant capital consolidation, reducing its share count by a factor of 31, and is introducing a facility to help small shareholders sell untradeable parcels post-consolidation.

Aldoro Resources has secured funding and acquired a state-of-the-art drilling rig to expand its Phase II drilling program at the Kameelburg REE-Niobium Project in Namibia, aiming to enhance resource definition and metallurgical testing.

Sarytogan Graphite Limited has secured a $1.4 million top-up placement from the European Bank for Reconstruction and Development, reinforcing confidence in its graphite project and supporting its feasibility study timeline.

Encounter Resources has completed the first tranche of its $25 million share placement, raising approximately $24.5 million to advance its mineral exploration projects. The second tranche, involving shares to a company director, awaits shareholder approval.

Scout Security has entered a binding agreement to acquire New York-based Roo Inc in a merger of equals, combining their complementary home security technologies and customer bases to create a scalable global security-as-a-service platform.

Mineral Commodities Ltd has terminated its sale agreement with Norge Mineraler for the Skaland Graphite Project due to non-payment and is now negotiating a new deal with LNS Holding AS.

Middle Island Resources has completed its acquisition of Konstantin Resources, issuing over 750 million new securities following shareholder approval. This marks a significant expansion in Middle Island's portfolio and capital structure.

Arafura Rare Earths secures an ASX waiver allowing eligible shareholders to vote on its upcoming Share Purchase Plan, ensuring broader participation in a key capital raising step.

Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.

TPG Telecom has announced a substantial special dividend and capital reduction totaling approximately AUD 3 billion, pending shareholder approval at the upcoming EGM.